Atomo Diagnostics Limited (ASX: AT1)
Health Care · Health Care Equipment & Supplies · AU
AU$0.02
+5.88% today · 0.0% 1Y
Atomo Diagnostics Limited (ASX: AT1) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $11.64M and employs 85 people.
Over the last twelve months the share price has gained 0.0%, trading between 0.02 and 0.05.
Tweenvest scores Atomo Diagnostics Limited across four factors: quality 30/100, value 60/100, growth 0/100. Its strongest factor is value.
AT1 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $11.64M
- Revenue (TTM)
- $2.61M
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- 1.10
- 52-week high
- AU$0.05
- 52-week low
- AU$0.02
- Avg volume (3M)
- —
- Shares outstanding
- 902.43M
- Employees
- 85
- Next earnings
- —
About Atomo Diagnostics Limited
Established in 2010 and based in Leichhardt, Australia, Atomo Diagnostics Limited is a global enterprise focused on the innovation and commercialization of medical devices. The company provides swift-result diagnostic tools designed for various applications, including COVID-19 detection, HIV screening, pregnancy confirmation, and assessing respiratory conditions.
- ISIN
- AU0000080327
- Founded
- 2010
- Listed since
- Apr 16, 2020
- Exchange
- Australian Securities Exchange
- Currency
- AUD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $201.88B | $115.60 | -0.92% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $131.97B | $371.71 | -0.50% |
| Stryker CorporationNYSE: SYK | $125.74B | $331.37 | +1.09% |
| Medtronic plcNYSE: MDT | $118.91B | $91.85 | -1.13% |
| EssilorLuxottica Société anonymeENXTPA: EL | $86.72B | €159.15 | -1.58% |
| Boston Scientific CorporationNYSE: BSX | $71.03B | $49.62 | +1.23% |
| Siemens Healthineers AGXTRA: SHL | $52.46B | €39.70 | -1.71% |
| HOYA CorporationTSE: 7741 | $52.35B | ¥24,895.00 | -1.37% |
Figures last refreshed Aug 18, 2026.